Max Vikström

2.1k total citations
33 papers, 752 citations indexed

About

Max Vikström is a scholar working on Immunology, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Max Vikström has authored 33 papers receiving a total of 752 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 8 papers in Physiology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Max Vikström's work include Atherosclerosis and Cardiovascular Diseases (8 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and Fatty Acid Research and Health (4 papers). Max Vikström is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (8 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and Fatty Acid Research and Health (4 papers). Max Vikström collaborates with scholars based in Sweden, United Kingdom and Netherlands. Max Vikström's co-authors include Ulf dé Fairé, Karin Leander, Bruna Gigante, Mai-Lis Hellénius, Johan Frostegård, Elin Ekblom‐Bak, Mai‐Lis Hellénius, Björn Ekblom, Jun Su and Roland Fiskesund and has published in prestigious journals such as Circulation, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Max Vikström

32 papers receiving 735 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Max Vikström Sweden 16 186 166 124 98 94 33 752
Jagoda Jorga Serbia 13 146 0.8× 155 0.9× 117 0.9× 187 1.9× 62 0.7× 38 701
Jing Bai China 13 93 0.5× 99 0.6× 122 1.0× 87 0.9× 78 0.8× 44 725
Yi‐Chou Hou Taiwan 22 70 0.4× 111 0.7× 106 0.9× 74 0.8× 222 2.4× 69 1.1k
Ming‐Chih Chou Taiwan 21 99 0.5× 209 1.3× 76 0.6× 154 1.6× 292 3.1× 64 1.3k
Özcan Balat Türkiye 20 100 0.5× 175 1.1× 269 2.2× 111 1.1× 72 0.8× 115 1.3k
Kristina L. Bailey United States 23 183 1.0× 177 1.1× 81 0.7× 154 1.6× 226 2.4× 76 1.3k
Deepesh Khanna United States 12 59 0.3× 254 1.5× 133 1.1× 187 1.9× 109 1.2× 48 898
Paweł Nadrowski Poland 11 75 0.4× 152 0.9× 120 1.0× 95 1.0× 82 0.9× 17 613
А. В. Стародубова Russia 16 176 0.9× 236 1.4× 304 2.5× 209 2.1× 345 3.7× 61 1.2k
Otilia Perichart‐Perera Mexico 17 87 0.5× 127 0.8× 352 2.8× 89 0.9× 44 0.5× 65 919

Countries citing papers authored by Max Vikström

Since Specialization
Citations

This map shows the geographic impact of Max Vikström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Vikström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Vikström more than expected).

Fields of papers citing papers by Max Vikström

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Vikström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Vikström. The network helps show where Max Vikström may publish in the future.

Co-authorship network of co-authors of Max Vikström

This figure shows the co-authorship network connecting the top 25 collaborators of Max Vikström. A scholar is included among the top collaborators of Max Vikström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Vikström. Max Vikström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Samal, Shailesh Kumar, et al.. (2023). Antibodies against malondialdehyde among 60-year-olds: prediction of cardiovascular disease. Scientific Reports. 13(1). 15011–15011.
2.
Vikström, Max, et al.. (2023). Metal ratios as possible biomarkers for amyotrophic lateral sclerosis. Journal of Trace Elements in Medicine and Biology. 78. 127163–127163. 4 indexed citations
5.
Leander, Karin, et al.. (2019). Low Socioeconomic Status Predicts Worse Outcome in Patients with Ruptured Abdominal Aortic Aneurysm. European Journal of Vascular and Endovascular Surgery. 58(6). e150–e150. 1 indexed citations
6.
Risérus, Ulf, Karin Leander, Per Sjögren, et al.. (2017). Serum Fatty Acids, Desaturase Activities and Abdominal Obesity – A Population-Based Study of 60-Year Old Men and Women. PLoS ONE. 12(1). e0170684–e0170684. 38 indexed citations
7.
Laguzzi, Federica, Ulf Risérus, Matti Marklund, et al.. (2017). Circulating fatty acids in relation to alcohol consumption: Cross-sectional results from a cohort of 60-year-old men and women. Clinical Nutrition. 37(6). 2001–2010. 14 indexed citations
8.
Frostegård, Johan, Jun Su, Hua Xiang, et al.. (2017). IgM antibodies to oxidized phosphatidylserine as protection markers in cardiovascular disease among 60-year olds. PLoS ONE. 12(4). e0171195–e0171195. 5 indexed citations
9.
Journath, Gunilla, Niklas Hammar, Stig Elofsson, et al.. (2015). Time Trends in Incidence and Mortality of Acute Myocardial Infarction, and All-Cause Mortality following a Cardiovascular Prevention Program in Sweden. PLoS ONE. 10(11). e0140201–e0140201. 16 indexed citations
10.
Quintana, Hedley, Max Vikström, Tomas Andersson, Johan Hallqvist, & Karin Leander. (2015). Agreement between Myocardial Infarction Patients and Their Spouses on Reporting of Data on 82 Cardiovascular Risk Exposures. PLoS ONE. 10(7). e0132601–e0132601. 3 indexed citations
11.
Tengvall, Sara, Bettina Levänen, Max Vikström, et al.. (2014). Interleukin-26 in Antibacterial Host Defense of Human Lungs. Effects on Neutrophil Mobilization. American Journal of Respiratory and Critical Care Medicine. 190(9). 1022–1031. 61 indexed citations
12.
13.
Brismar, Kerstin, et al.. (2014). The Metabolic Syndrome and ECG Detected Left Ventricular Hypertrophy – Influences from IGF-1 and IGF-Binding Protein-1. PLoS ONE. 9(12). e108872–e108872. 8 indexed citations
14.
Su, Jun, Hua Xiang, Max Vikström, et al.. (2013). Low levels of IgM antibodies to oxidized cardiolipin increase and high levels decrease risk of cardiovascular disease among 60-year olds: a prospective study. BMC Cardiovascular Disorders. 13(1). 1–1. 60 indexed citations
15.
Ekblom‐Bak, Elin, Björn Ekblom, Max Vikström, Ulf dé Fairé, & Mai‐Lis Hellénius. (2013). The importance of non-exercise physical activity for cardiovascular health and longevity. British Journal of Sports Medicine. 48(3). 233–238. 108 indexed citations
16.
Leander, Karin, Bruna Gigante, Angela Silveira, et al.. (2012). NAMPT (visfatin) and AKT1 genetic variants associate with myocardial infarction. Clinica Chimica Acta. 413(7-8). 727–732. 14 indexed citations
17.
Gigante, Bruna, Karin Leander, Max Vikström, et al.. (2012). Elevated ApoB serum levels strongly predict early cardiovascular events. Heart. 98(16). 1242–1245. 17 indexed citations
19.
Gigante, Bruna, Anna M. Bennet, Karin Leander, Max Vikström, & Ulf dé Fairé. (2010). The Interaction between Coagulation Factor 2 Receptor and Interleukin 6 Haplotypes Increases the Risk of Myocardial Infarction in Men. PLoS ONE. 5(6). e11300–e11300. 18 indexed citations
20.
Vikström, Max, et al.. (2006). Neighbourhood non-employment and daily smoking: a population-based study of women and men in Sweden. European Journal of Public Health. 16(1). 78–84. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026